Article

AJMC® in the Press, August 20, 2021

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article by International Business Times referenced an article published in a supplement to The American Journal of Managed Care® (AJMC®), titled “Economic Burden of Alzheimer Disease and Managed Care Considerations.” In assessing the financial burden of Alzheimer disease, researchers said that unless new treatments or cures are developed, current treatment costs of $305 billion per year will rise to more than $1 trillion by 2050.

A piece by The Week spotlighted a video interview published on AJMC.com, the website of AJMC®. The interview, “Dr William "Andy" Nish Debunks Common Reasons for Not Getting COVID-19 Vaccine,” discussed false beliefs about COVID-19 vaccination, and why there is no good reason not to get inoculated, especially as the Delta variant spreads.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Merrill H. Stewart, MD
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Merrill H. Stewart, MD
Dr CK Wang
Nini Wu, MD, Navista
Jonathan Strober, MD, UCSF Benioff Children's Hospital
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo